AdvisorShares Psychedelics ETF Rating $11.99 -0.14 (-1.15%) (As of 11/4/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingModerate Buy2.90Holdings in PSIL have an aggregate rating of Moderate Buy based on 78 analyst ratings issued in the past year covering 11 companies (60.3% of the portfolio).PSIL Aggregate Price Target$77.51546.64% UpsideHigh Prediction$115.47Average Prediction$77.51Low Prediction$48.81Holdings in PSIL have an aggregate price target of $77.51 and a range of $48.81 to $115.47 covering 11 companies (60.3% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy2 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 11 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.78%MNMDMind Medicine (MindMed)$6.06-1.3%1.555 of 5 stars3.25$25.38 318.7%12Upcoming Earnings5.83%CMPSCOMPASS Pathways$4.68-1.5%2.2525 of 5 stars3.00$30.67 555.3%7Earnings ReportAnalyst Forecast5.23%ALKSAlkermes$26.59+0.5%4.8919 of 5 stars2.50$34.90 31.3%104.99%RLMDRelmada Therapeutics$3.42-2.0%3.9442 of 5 stars2.00$7.50 119.3%2News Coverage4.91%GHRSGH Research$8.00-1.8%1.747 of 5 stars3.00$36.67 358.3%3News Coverage4.80%ATAIAtai Life Sciences$1.081.9284 of 5 stars3.00$10.50 872.2%34.50%ITCIIntra-Cellular Therapies$86.17-0.4%4.5923 of 5 stars2.85$96.62 12.1%13Earnings ReportAnalyst ForecastAnalyst Revision4.45%VTGNVistagen Therapeutics$3.22+3.5%2.5085 of 5 stars3.33$13.50 319.3%3Upcoming EarningsHigh Trading Volume4.30%NRXPNRx Pharmaceuticals$1.32-4.3%1.5519 of 5 stars3.33$31.50 2,286.4%3Upcoming Earnings4.19%SAGESage Therapeutics$5.81-4.0%4.31 of 5 stars2.00$12.89 121.8%21Earnings ReportAnalyst RevisionGap Down3.31%ENVBEnveric Biosciences$0.46-6.1%2.4011 of 5 stars3.00$10.00 2,055.2%1Upcoming EarningsNews CoverageGap Down This page (NYSEARCA:PSIL) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSIL Stock Alerts